Physician profile
Chitra Mathew
NPI 1356724728
$3,148.36
in general payments reported to CMS, 2019-2025
19 companies · $18.32 in 2025
The $18.32 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,476 · 2022: $912 · 2023: $568 · 2024: $173 · 2025: $18.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.04 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $483.51 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $470.27 | 2021-2023 | Abilify Mycite, Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $332.42 | 2021-2023 | |
| Alkermes, INC. | $268.38 | 2021-2024 | Lybalvi, Aristada, Vivitrol |
| Takeda Pharmaceuticals U.S.A., INC. | $153.32 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $143.36 | 2023-2024 | Austedo Xr |
| Lundbeck LLC | $140.58 | 2021-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $83.89 | 2022-2024 | Invega |
| Supernus Pharmaceuticals, INC. | $83.01 | 2021 | |
| Axsome Therapeutics, INC. | $77.88 | 2022-2023 | Auvelity |
| Eisai INC. | $66.51 | 2021 | |
| Avanir Pharmaceuticals, INC. | $58.84 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $48.08 | 2021 | |
| Bausch Health US, LLC | $27.49 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $18.32 | 2025 | Cobenfy |
| Adlon Therapeutics L.P. | $13.06 | 2021 | |
| Alfasigma USA, INC. | $12.80 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.60 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.